The proteasome refers to a collection of complexes centered on the 20S proteasome core particle (20S CP), a complex of 28 subunits that houses proteolytic sites in its hollow interior. Proteasomes are found in eukaryotes, archaea, and some eubacteria, and their activity is critical for many cellular pathways. Important recent advances include inhibitor binding studies and the structure of the immunoproteasome, whose specificity is altered by the incorporation of inducible catalytic subunits. The inherent repression of the 20S CP is relieved by the ATP-independent activators 11S and Blm10/PA200, whose structures reveal principles of proteasome mechanism. The structure of the ATP-dependent 19S regulatory particle, which mediates degradation of polyubiquitylated proteins, is being revealed by a combination of crystal or NMR structures of individual subunits and electron microscopy reconstruction of the intact complex. Other recent structural advances inform us about mechanisms of assembly and the role of conformational changes in the functional cycle. 
INTRODUCTION
This review summarizes advances made in understanding structural aspects of the proteasome, which is a protease found in eukaryotes, archaea, and some bacteria and is of critical importance for many facets of cellular metabolism because it performs most of the regulated protein turnover in the eukaryotic cytosol and nucleus. The proteasome exists as a collection of complexes that are centered on the 20S proteasome core particle (20S CP), an ∼700-kDa complex of 28 protein subunits. Since the first 20S CP structure was determined in 1995 (51), considerable progress has been made in understanding proteasome mechanisms, including an accelerating rate of advances in structural biology that include several important papers published in the past year.
Here we provide an overview of the current state of proteasome structural biology. We start with the 20S CP and, of the many publications on proteasome inhibitor complexes, highlight two notable recent advances: a difference in available conformational changes that may allow development of novel therapeutics for the treatment of tuberculosis, and an increased understanding of how the inducible subunits of the immunoproteasome favor production of ligands for major histocompatibility complex I (MHC-I) molecules. This is followed by a discussion of the activators that relieve the inherently repressed 20S CP structure, including the ATP-independent activators 11S and Blm10/PA200, whose biological function is unclear but for which structural studies have provided insight to biochemical mechanisms of proteasome binding and activation. The other class of 20S CP activators is ATP-dependent and includes the 19S regulatory particle (19S RP) of eukaryotes, which includes a core of six ATPases that unfold and translocate substrates to mediate most of the regulated proteolysis in the eukaryotic cytosol and nucleus. Archaea and some eubacteria encode the simpler ATP-dependent activators PAN, ARC, and Mpa, which are relatively simple homohexameric homologs of the 19S RP ATPases that lack the additional non-ATPase subunits of the 19S RP. The complete 19S RP and its complex with the 20S CP, known as the 26S Blm10: an ATP-independent activator named for the mistaken belief that it confers resistance to bleomycin; the yeast homolog of PA200 proteasome, is a topic for which especially exciting advances have been obtained recently in the form of reconstructions by electron microscopy (EM) that have revealed the relative location of all 19 subunits of the 19S RP. Finally, we review structural insights into the processes of assembly of the 20S CP and the 19S RP, and of their association to form the 26S proteasome. An emerging theme that runs throughout this review is that understanding of proteasome mechanisms requires insights into the conformational changes that occur during different facets of proteasome function.
19S regulatory particle (19S RP
)
20S CORE PARTICLE
The determination of a crystal structure of the 20S CP from the archaeon Thermoplasma acidophilum was a landmark achievement that revealed a cylindrical structure of four rings, with seven α subunits in each of the two end rings and seven β subunits in each of the two central rings (51). The catalytic centers were localized to the central chamber, and biochemical and structural studies of inhibitor complexes further revealed essential elements of the N-terminal nucleophile catalytic mechanism (75) . Whereas archaea and eubacteria typically encode a single α subunit and a single β subunit to assemble a sevenfold symmetric 20S CP, eukaryotes encode seven distinct α subunits (α1-7) and seven distinct β subunits (β1-7), which occupy unique positions to assemble a pseudo-sevenfold symmetric 20S CP, as revealed by a crystal structure of the 20S CP from the yeast Saccharomyces cerevisiae (24). This structure and associated inhibitor complexes also showed how distinctive S1 pockets define the specificity of the three catalytically active β1, β2, and β5 subunits of eukaryotes, which possess caspase, trypsin, and chymotrypsin-like activities, respectively. The subsequent crystal structure of the bovine 20S proteasome indicated that all eukaryotic 20S proteasomes have closely similar structures (90) (Figure 1 ).
Recent Advances in Inhibitor Development
A large variety of inhibitor complex crystal structures have been determined, largely because 20S CP inhibition is an established approach for cancer therapy, with the inhibitor bortezomib currently approved for the treatment of relapsed multiple myeloma and mantle cell lymphoma (31). Recently, crystal structures have been reported for the mouse liver 20S proteasome and immunoproteasome, a variant in which the three constitutive catalytic subunits are substituted by inducible counterparts that are upregulated in response to T cell signaling (30). These structures explain the basis for the change in specificity, which largely occurs through changes in the S1 pocket, and why the PR-957 inhibitor preferentially binds the β5i subunit. These findings give impetus to efforts to develop specific inhibitors that might be efficacious in the treatment of disorders in which immunoproteasomes are upregulated, such as some autoimmune disorders, neurodegenerative diseases, and cancers. Structural studies are also guiding efforts to develop inhibitors against the proteasome of pathogens, such as Mycobacterium tuberculosis, which causes tuberculosis. Interestingly, binding of oxathiazole-2-one inhibitors was shown to induce a conformational change that explains why these compounds show specificity for the M. tuberculosis proteasome, whereas the equivalent conformational change is not accommodated in eukaryotic proteasomes (49).
Gating
The entrance route for substrates through an axial pore in the α subunits was indicated by EM visualization of gold-labeled substrate bound to the T. acidophilum 20S CP (96) , while the crystal structure of the same 20S CP showed that the pore comprises a 13Å diameter constriction called the α annulus that limits entry to unstructured proteins (51). Passage through this pore is Each of the seven different α subunits and seven different β subunits occupies a unique position within its respective rings. The whole structure has twofold symmetry relating the top and bottom halves to each other, with the twofold axis in the horizontal plane (a little to the right of center in this view). (c) Cutaway view showing internal features. The S. cerevisiae 20S CP is shown in ribbon representation with just eight subunits displayed in order to reveal the hollow interior. Labeled features include residues that contribute to the asymmetric closed gate structure, loops that contribute to the α annulus, and the active sites of β1 and β5 in the lower β ring (only the β1, β2, and β5 subunits have active sites in eukaryotic proteasomes).
(d ) Conformational changes at the active site of Mycobacterium tuberculosis 20S CP that are induced upon binding of the inhibitor suggest the possibility of developing a specific therapeutic inhibitor (49). The loop connecting S4 and H1 of the β subunit moves from the unbound conformation (white, PDB ID: 2fhg) to cover OXZ, the inhibitor oxazolidin-2-one ring on Thr1 in the stabilized complex ( purple, PDB ID: 3h6f).
(e) Comparison of mouse liver constitutive and inducible β5 S1 binding pocket (30). Met45 adopts the sky blue conformation (PDB ID: 3unf) when bound to the PR-957 inhibitor, which binds with a large hydrophobic group in the S1 pocket. Met45 also adopts this conformation in the unbound immunoproteasome but adopts the tan conformation in the unbound constitutive proteasome (PDB ID: 3une). This requirement for repositioning Met45 explains why immunoproteasomes prefer to cleave substrates after large hydrophobic side chains.
further impeded by disordered polypeptides corresponding to the first 12 residues of the seven α subunits (4, 19). In contrast, the eukaryotic 20S CP adopts a precisely closed conformation (24). Bacterial proteasomes also appear to adopt an ordered closed gate, although the structure is strikingly different from that of eukaryotic proteasomes (47). Despite their different mechanisms of gate closure, it seems likely that fully activated proteasomes will all adopt the same sevenfold symmetric fully open conformation (82) .
Insights from NMR
Although most of the structural data on the 20S CP have been obtained by X-ray crystallography, NMR studies by the Kay group have made a number of notable contributions. These remarkable achievements, given the very large molecular weight, were made possible by the development of methyl transverse relaxation optimized spectroscopy using deuterated protein and selectively labeled amino acid methyl groups (on either methionine or isoleucine, leucine, and valine) (35). These studies were performed on the T. acidophilum 20S CP, which offers the advantage of providing a number of more tractable subassemblies, including a monomeric α subunit, a heptameric α ring, and a double α ring of 14 subunits, which provided a clearer view of many of the processes analyzed. This allowed the quantification of properties such as internal dynamics of specifically labeled residues and activator binding (79) . Insight into the mechanism of gate closure by the flexible N termini of archaeal proteasomes was provided by determining that on average two of the chains pass through the α annulus to the proteasome interior, thereby plugging the passage needed for protein substrates (64) . Using three model substrate proteins, this approach also demonstrated that the interior surface of the proteasome stabilizes an unstructured conformation of translocated substrates, thereby inhibiting refolding of stable protein domains inside the proteasome (67) . NMR methods have also guided new approaches to developing proteasome inhibitors by demonstrating that inhibition can be achieved by binding in the vicinity of the interface between α and β subunits in a manner that is independent of binding to the active sites (80) .
ATP-INDEPENDENT ACTIVATORS

11S Activators
The 11S activators, as illustrated by a crystal structure of the human PA28α/REGα homolog, are toroidal heptamers that present sevenfold symmetric arrays of proteasome-binding C-terminal residues and internal activation loop residues on one surface (37). The 20Å pore through this heptamer was initially suggestive of a substrate entry channel, although it was subsequently found that this channel is occluded in the distantly related PA26 homolog of Trypanosoma brucei ∼250-kDa activator wrapping around the end of the proteasome α subunits like a turban (68) . Curiously, Blm10 induces a disordered 20S CP gate conformation, and only limited access to the dome-like structure formed by Blm10 over the proteasome entrance pore is apparent, which is consistent with the relatively low level of peptidase stimulation by Blm10 compared to PA26 (34). The crystal structure did reveal that the one C terminus of Blm10 binds between the 20S proteasome α5 and α6 subunits, with the C-terminal three residues overlapping closely with the C termini of PA26 and forming the same main chain hydrogen bonds and salt bridge to the pocket lysine of α6. This does not result in complete gate opening, because other α subunits are not fully repositioned and because conserved Blm10 residues impede the fully open conformation, but it does provide an attractive model for the mechanism of binding of the ATP-dependent activators, which also appear to utilize a salt bridge between the activator C-terminal carboxylate and the pocket lysine (18) and, like Blm10 (12, 68) , display a functionally important penultimate tyrosine (or phenylalanine) (77) . In this model, the ATP-dependent activators reposition the proteasome Pro17 turns to the same open position seen in the PA26 complexes, albeit through different interactions. This model has been supported by two studies of crystal structures of PA26 mutants in complex with the archaeal 20S proteasome (81, 101) , although with some differences in interpretation, and by an EM reconstruction of PAN C-terminal peptides in complex with the 20S proteasome (61) .
Biological Function of the ATP-Independent Activators
Although the Blm10 and PA26 complex structures provide a wealth of biochemical insight, they do not clarify the rather confused understanding of biological function for either activator (63) . For example, a large literature implicates some 11S homologs in the production of ligands for MHC-I molecules, although a mechanism for this process is not securely established and many species that express an 11S homolog do not encode MHC-I (76). One of the 11S homologs, PA28γ/REGγ, is reported to promote the degradation of some natively unstructured transcription factors (9, 48). There is even more confusion for Blm10/PA200, for which there almost seems to be as many proposed biological functions as there are publications (72) . One attractive possibility is that the 11S and Blm10/PA200 activators function in the context of hybrid proteasomes, in which different classes of activator, including the ATP-dependent 19S activator, bind to opposite ends of the same 20S proteasome.
ATP-DEPENDENT ACTIVATORS
26S Proteasome
In contrast to the 11S and Blm10/PA200 activators, the biological function of the ATP-dependent 19S RP is well established to be the selection, conditioning, and delivery of substrates for proteolysis, especially those modified by conjugation to a polyubiquitin chain (17) 
ATPase Subunits of the 19S Regulatory Particle
The Rpt subunits are members of the classical family of AAA ATPases (16). Rpt1-6 form a heterohexameric ring at the heart of the eukaryotic 19S RP, while the homologous PAN and ARC/Mpa activators of archaea and eubacteria are homohexamers that form functional proteasome activators in the absence of additional subunits. These ATPases comprise an N-terminal coiled-coil (CC) domain, a central oligonucleotide/oligosaccharide binding (OB) domain, and a C-terminal
SUBUNITS AND ASSOCIATED PROTEINS OF THE 19S RP
The structure and organization of subunits associated with the 19S activator are illustrated in Figure 3 . This sidebar summarizes the key structural details and cites the coordinates shown. Rad23. Structures from (93) (PDB ID: 1qze). This shuttle receptor comprises four folded domains that are connected by flexible linkers. The UBA domains bind ubiquitin, or in its absence can bind its own Ubl domain. The Ubl domain binds Rpn1, which is shown in blue in the central panel but not in an expanded view because it is a homology model based on the structure of Rpn2.
Ubp6. Structure of this ubiquitin aldehyde (Ubal) complex from (29) (PDB ID: 2ayo). Ubp6 is a deubiquitylating enzyme that binds Rpn1 through its Ubl domain, whose structure has not yet been determined.
Rpn13. Structures from (10, 74) (PDB IDs: 2z59 and 2kqz). Rpn13 binds a flexible sequence at the C terminus of Rpn2 through its N-terminal PRU domain, which also binds ubiquitin. In most species, although not S. cerevisiae, the PRU domain is followed by a flexible linker and a helical C-terminal domain that binds the deubiquitylating enzyme Uch37.
Rpn2. Structure from (27) (PDB ID: 4ady). Rpn2 is the second largest 19S RP subunit after Rpn1, and also provides a homology model for Rpn1. These proteins comprise a helical toroid domain from which a helical Nterminal rod domain and a mostly β C-terminal domain project on one side. The C terminus of the ordered structure, from which the Rpn13 binding site projects, is labeled CT.
Rpn6 and Rpn12. Structures from (6, 56) (PDB IDs: 3txm and 4b0z). These proteins closely resemble each other and serve as homology models for Rpn3, Rpn5, Rpn7, and Rpn9.
Rpn8 and Rpn11. The model of this heterodimer follows the analysis of Reference 3 and the crystal structure of Rpn8/MOV34 (70) (PDB ID: 2o95). Rpn11 is the enzyme that removes ubiquitin from substrates as they are translocated by the ATPases. Rpn8 shares sequence similarity with Rpn11 but lacks active site residues.
Rpn10. The N-terminal VWA domain (65) (PDB ID: 2x5n) is followed by a flexible segment that includes one (in yeast) or two UIM domains as seen in this structure of a human S5a construct in complex with diubiquitin (104) (PDB ID: 2kde).
Rpt1-6. The Rpt subunits form a hexamer that is modeled in the side view of the central panel. This is based on the structure of the N-terminal CC-OB hexamer (102) (PDB ID: 3h43), which is shown from the top in the upper panel, and the structure of a monomeric PAN ATPase cassette (102) (PDB ID: 3h4m), which is docked into a hexamer based on the EM map and viewed from the bottom in the lower panel.
AAA ATPase cassette. Crystal structures of the OB domain and portions of the CC domain of archaeal and eubacterial homologs revealed a symmetry mismatch between the sixfold rotational symmetry of the OB domain ring and a trimer of dimers formed by the CC domains that is accommodated by formation of a cis proline conformation in three of the six subunits (13, 95, 102, 103) . The sequence requirements of this interaction guided cross-linking experiments that defined the order of the unique ATPase subunits in the ring of the 19S activator to be Rpt1-Rpt2-Rpt6-Rpt3-Rpt4-Rpt5 (89), in agreement with an earlier EM study (20) .
The three coiled coils projecting at the N-terminal face of the ATPase hexamer resemble chaperones such as profilin and can promote protein unfolding (13), an activity that likely conditions substrates prior to their entrance through the central 13Å diameter ring of OB domains. Moreover, the eubacterial Mpa coiled coils directly bind the Pup (prokaryotic ubiquitin-like protein) tag of conjugates targeted for degradation by pupylation (94) . The need for substrate to reach from the distal side of the OB pore to the pore loops of the ATPase cassette, the structural features that engage and actively translocate substrate in an ATP-dependent manner, explains why substrates displaying a 30-to 40-residue segment of unstructured polypeptide are efficiently hydrolyzed, 
tag can be on a subunit of a complex separate from the subunit that displays an unstructured segment and is degraded (58) . Because the unstructured initiation sequence can be on either the N or the C terminus of the substrate, it seems that the ATPases can translocate protein chains in either direction (59) , and the finding that proteolysis can start from flexible loops that are removed from either terminus indicates that more than two chains can pass through the channel at the same time (50, 62). The finding that some domains within substrate proteins can escape degradation is explained by the requirement that continued translocation can only occur if the translocating sequence engages efficiently with the ATPase pore loops and the domain entering the ATPase conduit does not strongly resist unfolding (88) .
Non-ATPase Subunits of the 19S Regulatory Particle
The two largest 19S subunits, Rpn1 and Rpn2, share low sequence identity but display similar three-dimensional structures, and each binds at least one ubiquitin receptor and a deubiquitylating enzyme. A crystal structure of S. cerevisiae Rpn2 revealed a central domain composed of 11 proteasome/cyclosome (PC) repeats in which the inner and outer PC helices form a closed ring that is filled by two additional helices (27). Projecting from one face of this central domain are an N-terminal rod-like domain of 17 stacked helices and a globular C-terminal domain comprising the β structure. Negative stain EM analysis of purified Rpn1 indicates that it shares this architecture, with some reorientation of the rod domain. This study also found that the C-terminal 20 residues of Rpn2 are unstructured and mediate binding to the Rpn13 subunit.
Earlier work had shown that Rpn13 comprises an N-terminal domain that binds ubiquitin and is called the pleckstrin-like receptor for ubiquitin (PRU) domain (32, 74). In most species, this domain is followed by an unstructured linker (∼150 residues in human) and a helical C-terminal domain (10) that provides the primary binding module for the Uch37/Uch-L5 deubiquitylating enzyme (25, 60, 99), which likely functions to edit inappropriately or inadequately ubiquitylated conjugates and to disassemble free ubiquitin chains (42). Crystal structures of Uch37 show that it comprises a catalytic domain that closely resembles structures of other UCH enzymes, followed by a C-terminal helical segment that includes the Rpn13-binding epitope (8) . Interestingly, Uch37 is activated by association with Rpn13 (60, 99) , and its specificity is altered by association with the 19S activator (41).
Rpn1 is also the binding module for the shuttle ubiquitin receptors Rad23 and Dsk2 and the deubiquitylating enzyme Ubp6/USP14 (14, 46, 66). These proteins all bind through their N-terminal Ubl domains with micromolar binding affinity, and the Ubp6 catalytic domain provides an additional interaction that results in nanomolar affinity for the full-length protein. This is consistent with the respective roles of Rad23 and Dsk2 as transiently associating shuttle receptors and of Ubp6 as an integral 19S RP subunit. A recent report concluded that the three Ubl domains preferentially bind to different regions of Rpn1 (66) .
Ubp6/USP14 employs the same cysteine protease mechanism as Uch37 but belongs to the distinct Ubp structural class (29). It is of special interest because its inhibition enhances degradation of some proteasome substrates implicated in neurodegenerative disease (45). As with the case of Uch37 binding to Rpn13, Ubp6 is activated by association with Rpn1 (46), and Ubp6 also seems to modify 19S RP structure because its binding delays proteolysis by a mechanism that is independent of its catalytic activity (26). Another example of functionally important conformational change is provided by the shuttle receptors, which likely adopt an autoinhibited conformation that is opened to release their Ubl domains for proteasome association upon binding of ubiquitylated substrate to the shuttle's Uba domains (23).
EM Reconstructions of the 26S Proteasome
The overall architecture of the 19S RP has been revealed in a recent flurry of EM reconstructions of 26S proteasomes from S. cerevisiae, S. pombe, and H. sapiens (3, 7, 11, 43, 44, 56, 69) . Two of the highest-resolution reconstructions, both of which were performed on the S. cerevisiae complex, used different approaches to assign all the subunits to regions of the reconstructed map. One study coexpressed the nine lid subunits in Escherichia coli, which allowed for the lid structure to be determined separately and for the N and C termini of specific subunits to be localized by expressing fusions with maltose-binding protein (43). The alternative approach of incorporating cross-linking data and computational methods of map fitting has provided a similar model at ∼7Å resolution (3).
A provocative observation from the ∼7Å resolution reconstruction is that the two 19S RP complexes bound to one 20S CP are not identical to each other (3). Significant differences are indicated, although currently only the more precisely defined RP structure has been discussed in detail. It is not apparent how conformational changes might propagate through the 20S CP in order to provide communication between the two 19S RP binding surfaces, which would presumably be a requirement for asymmetry to be an inherent property of fully assembled complexes. The potential of allosteric communication between two ends of a 26S proteasome complex and between the 20S CP proteolytic sites and the 19S RP is therefore an interesting but currently unresolved possibility. Another possibility is that a fraction of the double-capped 26S proteasomes analyzed had an alternative binding partner such as Bm10 at one end or a defect in one of the RPs, such as a partly assembled/disassembled conformation. Thus, the alignment procedure would have favored superimposing the most clearly defined 19S RPs at one end of the reconstruction, with all the less clearly defined 19S RPs at the opposite end, where the inclusion of noise would yield apparent structural differences. Resolving this issue and understanding the possibility of allostery between two ends of the 26S proteasome will be important challenges as the structural studies are pushed to higher resolution.
A surprise from these studies is that the lid sits on the side of the 19S RP rather than on the top, as had been generally imagined. Rpn3, 5, 6, 7, 9, and 12 associate in a horseshoe-like configuration through their PCI modules, and their N-terminal solenoid domains radiate widely. This allows Rpn6 and, to a lesser extent, Rpn5 to contact the C termini of 20S α2 and α1, respectively, and so presumably contribute to the overall stability of the 26S complex. This is consistent with a very recent report indicating that increased expression of Rpn6 confers resistance to proteotoxic stress and increases longevity in Caenorhabditis elegans, perhaps because increased Rpn6 promotes stability of the active 26S proteasome complex (92) . Rpn8 and Rpn11 dimerize through their MPN domains, and their C-terminal helices associate with the C-terminal helices of the six PCI-containing lid subunits in a bundle arrangement (3). This configuration places the Rpn11 deubiquitylase over the mouth of the ATPases, and superposition with a structure of the homologous AMSH enzyme bound with diubiquitin (71) supports the model that Rpn11 removes ubiquitin as substrate enters the ATPase channel.
The Rpt1-6 ATPases form a hexameric ring in which the N-terminal domains project upward to contact other 19S RP subunits, and the ATPase cassettes lie close to the 20S CP α subunits. The C termini of Rpt2, Rpt3, and Rpt5, which are the ATPase subunits that display C-terminal HbYX motifs, dock at the α3/α4, α1/α2, and α5/α6 pockets, respectively, consistent with findings from site-directed cross-linking data (87) . The details of these interactions are not currently resolved but presumably resemble the structures seen earlier for the ATP-independent activators.
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Another major surprise is that the pore region of the ATPase subunits assemble into a spiral staircase-like arrangement, with the lowest and highest subunits, Rpt2 and Rpt3, respectively, separated by Rpt6 in an intermediate position (3, 43) . It is generally thought that hexameric ATPase unfoldases, including the proteasome, function in a mixed nucleotide state, with ATP or ADP bound to some subunits while other subunits are unbound (22, 28, 78) . Beautiful structures of analogous nucleic acid helicases provide models for how propagation of a wave of conformational changes, driven by ATP binding, hydrolysis, and release around the ring, is coupled to translocation of the bound substrate (15, 86). The homohexameric nucleic acid helicase structures revealed a spiral configuration, analogous to that of the proteasome Rpt subunits, presumably because they were complexes with substrate, which induces asymmetry, and because crystallization selected just one of the six orientations that represent propagation of the spiral staircase conformation around the ring. It is not clear, however, how to reconcile this attractive "wave" model of the helicases with the proteasome reconstructions because, unlike the constraints of a crystal lattice, the 26S proteasome EM reconstructions are not expected to favor one particular arrangement of the propagating ATPase spiral, and the multiple staircase configurations would presumably appear as an averaged/blurred map with an apparently more circular arrangement of ATPase density. Thus, understanding the mechanistic implications of the defined spiral conformation observed for the Rpt subunits presents a challenging and enticing problem for future studies.
It is striking that the ubiquitin receptor subunits Rpn10 and Rpn13 are located at the distal end of the activator from the 20S proteasome interface. Similarly, the ubiquitin shuttle receptors are likely to be bound distant from the entrance to the ATPase hexamer. This arrangement is consistent with the model that ubiquitin binding promotes degradation by increasing the affinity of tagged substrate, without playing a more direct role in the processes of unfolding or translocation. Nevertheless, important functional questions remain, including the possibility of coordination between different ubiquitin-binding sites, the mechanistic basis for preference of binding polyubiquitin rather than monoubiquitin, and the possibility of coupling between ubiquitin binding and substrate processing by the ATPases (57) .
The location of deubiquitylating enzymes within the 19S RP is of mechanistic relevance. As discussed above, Rpn11 is poised to remove ubiquitin as substrate enters the ATPase channel. Interestingly, the substantial conformational differences seen between the isolated lid and the 26S proteasome may serve to maintain Rpn11 in an inactive state until assembly is completed, with a possible trigger for the conformational change being association of Rpn5 with the 20S CP (43). The more peripheral locations inferred for Uch37 and Ubp6/USP14 are consistent with their likely roles in editing. The EM reconstructions suggest that Rpn1-Upb6 may have some mobility within the 19S RP, and Uch37 is likely to enjoy considerable conformational freedom due to the flexible ∼150-residue linker between the Rpn13 N-terminal PRU domain that binds Rpn2 and the C-terminal domain that binds Uch37. This flexibility may allow Uch37 and Ubp6 to efficiently disassemble polyubiquitin chains that might otherwise clog the 26S proteasome. Ubp6 also provides an additional example of the complexity of proteasome regulation and the importance of further studies to understand conformational changes, because its binding is reported to regulate proteasome activity independently of its catalytic activity (26).
PROTEASOME ASSEMBLY Assembly Chaperones of the 20S Core Particle
In most species, 20S CP assembly proceeds with formation of a ring of α subunits followed by addition of β subunits to form half proteasomes, which dimerize to form the 20S CP, with a final maturation step coupled to cleavage of the β subunit propeptides (53). Assembly is promoted by chaperones, including the heterodimer Pba1-Pba2/Poc1-Poc2/PAC1-PAC2, which associates with the assembling 20S CP from the earliest stages of α ring formation to completion of the mature 20S CP. Although biochemical studies indicate that archaeal 20S proteasomes do not require assembly factors, the archaeal proteins PbaA and PbaB are thought to function analogously to the eukaryotic Pba1-Pba2 (39). The structure of a complex between Pba1-Pba2 and the 20S CP demonstrates that Pba1-Pba2 directly contacts α4, α5, α6, and α7, and that it binds through its C-terminal residues using principles similar to those observed for PA26 and Blm10, although Pba1-Pba2 itself is not a proteasome activator (83) . Binding of Pba1-Pba2 does not substantially alter 20S CP structure, suggesting that binding may promote assembly by stabilizing the correct relative positions of α subunits (Figure 4) .
Although it is unrelated to Pba1-Pba2, the Pba3-Pba4/Dmp3-Dmp4/PAC3-PAC4 heterodimer also chaperones early stages of 20S CP assembly. The crystal structure of Pba3-Pba4/ Dmp3-Dmp4 in complex with α5 demonstrates that binding occurs on the face opposite of that contacted by Pba1-Pba2, which explains why Pba3-Pba4 dissociates as β subunits are added following assembly of the α ring (100). The interaction with Pba3-Pba4 is important for promoting the appropriate association of α subunits, especially α3 and α4; α3 is notable for being nonessential in yeast, with α4 able to substitute in the case of α3 deficiency (38).
The final stages of associating two half proteasomes is promoted by Ump1, which is degraded upon proteasome assembly (52). Although structural data are not available for Ump1 interactions, structural insights into the final stages of maturation have been provided by the crystal structure of a mutant Rhodococcus proteasome that retains its propeptides. This finding reveals that the propeptide contacts two adjacent α subunits, thereby promoting assembly (40). Similarly, the structure of another mutant Rhodococcus proteasome guides models of the detailed structural requirements for maturation (98) .
Assembly Chaperones of the 19S Regulatory Particle
Assembly of the 19S RP base complex is facilitated by four chaperones, Hsm3/S5b, Nas2/p27, Rpn14/PAAF1, and Nas6/gankyrin (55) . The leading model holds that assembly proceeds via formation of three subcomplexes, each containing two of the ATPases, one or two chaperones, and in one case an Rpn subunit: Hsm3-Rpn1-Rpt1-Rpt2, Nas6-Rpn14-Rpt3-Rpt6, and Nas2-Rpt4-Rpt5. Addition of Rpn2, Rpn13, and Rpn10 completes formation of the base, which is followed by addition of the lid to form the 19S RP that associates with the 20S CP to form the 26S proteasome. Interestingly, each base chaperone binds to the C-terminal domain of a specific Rpt ATPase (Hsm3-Rpt1, Nas2-Rpt5, Nas6-Rpt3, Rpn14-Rpt6). Despite this functional similarity, the four base chaperones adopt different structures, as indicated by the sequence prediction of a PDZ domain for Nas2 and by crystal structures that show Nas6 comprises ankyrin repeats (54), Rpn14 forms a WD40 propeller (36), and Hsm3 comprises HEAT repeats (84) . The mechanism of binding to Rpt C termini was revealed for Hsm3 and Nas6, whose structures were determined as complexes with the Rpt1 and Rpt3 C-terminal domains, respectively. Docking of these complex structures onto the EM model of the 26S proteasome indicates that binding of Hsm3 and Nas6 is incompatible with the assembled structure due to clashes with the 20S CP. This modeling also suggests that Hsm3 may clash with Rpt5, although this apparent overlap may be relieved by relatively modest conformational changes. In addition, the modeling implies that binding of Nas6 is incompatible with the positions of Rpn5 and Rpn6 in the 26S proteasome, which may indicate that Nas6 regulates association of the base and lid. Due to the location of the Rpt Cterminal domains, it is likely that binding of Nas2 and Rpn14 are also incompatible with 19S RP-20S CP association, and clashes between Hsm3 and Nas2 also seem possible. Thus, despite 
IMPLICATIONS FOR FUTURE STUDIES
Recent years have seen remarkable progress in proteasome structural biology. Detailed structures are available for the 20S CP including numerous complexes with active site inhibitors, two ATPindependent activator complexes, several isolated 19S RP subunits, and several 20S CP and 19S RP chaperone complexes. Moreover, EM reconstructions coupled with high-resolution structures of individual subunits are providing valuable models of the 26S proteasome. Major goals for future structural studies include pushing models of the 26S proteasome to higher resolution and providing structural information on additional proteasome complexes, such as the numerous proteins reported to interact substoichiometrically with the proteasome (5, 91), and the recently reported functional association, at least in archaea, of the 20S CP with Cdc48 (2). Conformational changes are an important component of proteasome function. This is most apparent for the 19S RP ATPases, which drive substrate unfolding and translocate substrate into the 20S CP. Understanding how these Rpt subunits move during ATP binding and hydrolysis, and whether the pore regions remain in the spiral staircase configuration seen in the EM reconstructions or undergo a wave of conformational changes analogous to those proposed for the Rho and E1 helicases, is a high priority. The functional importance of movement is also evident for the ubiquitin receptors and for the associated deubiquitylating enzymes, and it will be important to understand how binding and conformational changes are coordinated and how they function to regulate proteasome activity. Finally, changes in association are explicit in the processes of proteasome assembly, and one exciting possibility for future functional studies is that these changes might be regulated events of physiological importance.
SUMMARY POINTS
1. The proteolytic sites of 20S CPs are sequestered in a hollow structure that promotes protein unfolding, and are accessed via gates through the α subunits that are closed by different mechanisms in eukaryotes, archaea, and eubacteria.
2. Proteasome inhibitors offer therapeutic potential, with recent advances including structures that explain the basis for a specific M. tuberculosis 20S CP inhibitor and the increased preference for hydrophobic P1 residues in the immunoproteasome. 4. The structures of many 19S RP subunits have been determined at atomic resolution either directly or on the basis of homology modeling.
5. Electron microscopy has recently produced models of the 26S proteasome at ∼7Å resolution. Especially important insights include the overall arrangement of base and lid subcomplexes, the location of ubiquitin receptors and deubiquitylating enzymes, and the arrangement of the Rpt ATPase subunits.
6. Proteasome assembly follows a highly regulated pathway that is guided by molecular chaperones that promote some specific subunit interactions and appear to inhibit other interactions until the appropriate binding partners are assembled.
7. There is considerable scope for future structural studies, including a need for higherresolution structures of the 26S proteasome, understanding the importance of numerous implied conformational changes and other dynamic processes such as binding/release of substoichiometric binding partners, and the potential role of additional activators such as Cdc48.
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